Our story

Lead Pharma develops innovative small-molecule therapies for patients with autoimmune disease, metabolic disease or cancer.

 

 

Management Board

Frans van den Berg

Frans van den Berg, MSc, MBA
Chief Executive Officer

Frans van den Berg, MSc, MBA
Chief Executive Officer

Arthur Oubrie

Arthur Oubrie, PhD
Chief Scientific Officer

Arthur Oubrie, PhD
Chief Scientific Officer

 

Investors

819 Capital Partners
Biox Biosciences
Waterman Ventures